Foresight Acquisition Corp. (NASDAQ:FORE) and P3 Health Partners Announce Adjournment of Special Meeting
for Proposed Business Combination
Special meeting of Foresight Acquisition Corp. stockholders to approve the proposed business
combination adjourned to Wednesday, November 24, 2021 at 7:00 a.m. Central Time.
New York, NY November 18, 2021
Foresight Acquisition Corp. (NASDAQ: FORE) (Foresight) announced that its Special Meeting of Foresights stockholders (the Special Meeting) relating to the proposed business combination (the
Business Combination) with P3 Health Partners (P3) was convened today at 9:00 a.m. Central Time and adjourned until 7:00 a.m. Central Time on November 24, 2021. The Special Meeting was adjourned to give Foresights
stockholders additional time to consider additional disclosure to be included in a supplement to the Proxy Statement that was filed with the Securities and Exchange Commission (SEC) on October 28, 2021 (the Proxy
Statement) and mailed to Foresights stockholders, including expected changes to certain pro forma financial information related to the determination that the Business Combinations should be accounted for as a business combination using
purchase accounting adjustments rather than as a reverse recapitalization as currently provided for in the Unaudited Pro Forma Financial Statements in the Proxy Statement. These changes will have no impact on the historical financial statements of
P3 or Foresight that were included in the Proxy Statement. Foresight expects to file a supplement to the Proxy Statement on or prior to Monday, November 22, 2021.
No changes have been made to the record date, the location of the meeting or the proposals to be voted on at the Special Meeting, which are presented in
Foresights Proxy Statement filed with the Securities and Exchange Commission on October 28, 2021. The re-convened meeting will be held virtually at
https://www.cstproxy.com/foresightacq/2021. Only the holders of Foresights common stock as of the close of business on October 8, 2021, the record date for the Special Meeting, are entitled to vote at the Special
Meeting.
If you have already submitted your proxy, you do not need to take any action unless you wish to change your vote. You retain the power to revoke
your proxy or change your vote at any time before it is voted at the Special Meeting on November 24, 2021. Only the most recent proxy vote will be counted and all others will be discarded regardless of the method of voting. If a broker or other
nominee holds your stock on your behalf, you must contact your broker, bank or other nominee to change your vote. As a result of the adjournment, Foresight stockholders will be able to continue to change their redemption election on or prior to 5:00
Eastern Time on Monday, November 22, 2021.
If the proposals at the Special Meeting are approved, the parties anticipate that the Business
Combination will close as promptly as practicable after the meeting, subject to the satisfaction or waiver (as applicable) of all other closing conditions.
About Foresight Acquisition Corp.
Foresight is a special
purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. For more information, visit
foresightacq.com.
About P3 Health Partners
P3 is a patient-centered and physician-led population health management company. Founded and led by
physicians, P3 is a team of doctors, clinicians and support service professionals with a shared passion for delivering value-based care. We leverage our deeply integrated and capital efficient care model, data and technology, physician leadership
and community outreach tools to create enhanced patient outcomes and experiences, greater satisfaction for providers and caregivers and lower care costs. For more information, visit p3hp.org.